Home › Frost & Sullivan Recognizes KAER's Game-Changing Innovating Aerosol Drug Delivery Methods For High-Dose Respiratory Disease Therapeutics
 

Keywords :   


Frost & Sullivan Recognizes KAER's Game-Changing Innovating Aerosol Drug Delivery Methods For High-Dose Respiratory Disease Therapeutics

2013-02-27 02:15:32| drugdiscoveryonline News Articles

Based on its recent analysis of the aerosol drug delivery technology market, Frost & Sullivan recognizes KAER Biotherapeutics with the 2012 North America Frost & Sullivan Award for Technology Innovation for SUPRAER

Tags: methods delivery drug disease

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05Eastern North Pacific Tropical Weather Outlook
20.05Atlantic Tropical Weather Outlook
20.05We Recycle Solar Expands Partnership with Renewables.org
20.05Washington State Authorizes Drone for Methane Emissions
20.05The Heart, Science & Business of Sustainability: A Fireside Chat with Tara Hemmer
20.05Commissioners Celebrate the Opening of New Waste Transfer Station in Redmond, Ore.
20.05Newhaven Food Waste Facility Plans Paused Following Residents Concerns
20.05Business Report May 2024Highlights from WasteExpo 2024
More »